Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RPL3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | IDH3A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | RFX5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | NRG2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TMEM183A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | MYOZ3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PIM2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | COQ10B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | PTRH1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |